tb-500 for athletes: Frequently asked questions

Reassess timing, dosage, and injury type. TB-500 works best on acute soft-tissue injuries (muscle strains, tendon microtears) during the proliferative phase of healing (days 3–21 post-injury). If you're treating a chronic condition or scar tissue that's already remodeled, actin upregulation has limited effect because the injury is past the angiogenic window. Chronic tendinopathy often requires 6–8 weeks of consistent dosing before structural changes are measurable. If dosing is correct and timing is appropriate, verify peptide purity with third-party testing. Sequence errors or low-purity synthesis render the compound ineffective.

Discard it immediately. Once reconstituted with bacteriostatic water, TB-500 must be refrigerated at 2–8°C and used within 28 days. Peptide bonds break down rapidly at ambient temperature. After 24 hours above 8°C, the actin-binding domain loses structural integrity, and the compound becomes biologically inactive. There is no visual indicator of degradation. You cannot salvage partially degraded peptides by re-refrigerating them. The damage is irreversible.

Chronic tendinopathy. Defined as symptoms persisting beyond 12 weeks despite structured rehabilitation. Represents the injury type where athletes researching tb-500 see the most consistent anecdotal benefit. The mechanism aligns: chronic tendon injuries often have poor vascularisation, and TB-500's angiogenic effects directly address that deficit. Load management remains essential. The peptide accelerates healing, but continuing high-impact activity during the repair phase negates any benefit. Combine TB-500 with eccentric loading protocols (the gold standard for tendinopathy rehab) rather than replacing conventional treatment entirely.

Post-surgical TB-500 administration should begin during the proliferative phase of healing, typically 5–10 days after surgery once initial inflammation subsides. Starting too early doesn't accelerate the inflammatory phase meaningfully and may interfere with surgical site hemostasis. Coordinate timing with your surgeon if possible. Though most orthopedic surgeons are unfamiliar with research peptides, the mechanism (promoting angiogenesis and collagen deposition) aligns with standard post-op healing goals. Expect 8–12 week protocols post-surgery, not the shorter 4–6 week courses used for non-surgical injuries.

Any temperature excursion above 8°C for more than 4–6 hours causes partial or complete protein denaturation. The peptide may look clear and unchanged, but bioactivity degrades irreversibly. Injecting it won't cause harm, but it also won't deliver therapeutic benefit. Discard the vial and reconstitute a fresh dose. This is why athletes traveling with peptides need purpose-built cooling solutions, not just ice packs in a gym bag. Our team has seen more protocol failures from storage errors than from incorrect dosing.

Administer the missed dose as soon as you remember if fewer than 3 days have passed, then resume your regular schedule. If more than 3 days have passed, skip the missed dose and continue with your next scheduled administration. Do not double-dose to compensate. TB-500's effect is cumulative over the 4–6 week loading phase, so one missed dose does not negate prior progress. Consistency matters more than perfection.